Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy-Reference-Cited by-同舟云学术

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Published:2014-01-14 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Akamatsu Hiroaki,Mori Keita,Naito Tateaki,Imai Hisao,Ono Akira,Shukuya Takehito,Taira Tetsuhiko,Kenmotsu Hirotsugu,Murakami Haruyasu,Endo Masahiro,Harada Hideyuki,Takahashi Toshiaki,Yamamoto Nobuyuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-18.pdf

Reference16 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.

2. Govindan R, Bogart J, Vokes EE: Locally Advanced Non-small Cell Lung Cancer: The Past, Present, and Future. J Thorac Oncol. 2008, 3: 917-928. 10.1097/JTO.0b013e318180270b.

3. Reinfuss M, Glinski B, Kowalska T, Kulpa J, Zawila K, Reinfuss K, Dymek P, Herman K, Skolyszewski J: Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients). Cancer Radiother. 1999, 3 (6): 475-479. 10.1016/S1278-3218(00)88254-2.

4. Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Dar AR, Turrisi A: Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer. Chest. 2000, 117: 358-364. 10.1378/chest.117.2.358.

5. Auperin A, Le Pe’choux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP: Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer. J Clin Oncol. 2010, 28: 2181-2190. 10.1200/JCO.2009.26.2543.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization;Cancer Medicine;2024-01

2. Clinical value of serum albumin level in patients with non-small cell lung cancer and anaplastic lymphoma kinase (ALK) rearrangement;Annals of Palliative Medicine;2021-12

3. Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis;Investigational New Drugs;2021-10-30

4. Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L);BMC Cancer;2021-10-18

5. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study;Frontiers in Pharmacology;2021-09-02